Header Logo

Connection

WOLFGANG WINKELMAYER to Retrospective Studies

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Retrospective Studies.
WOLFGANG WINKELMAYER
Connection Strength
1.332
Retrospective Studies
  1. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360.
    View in: PubMed
    Score: 0.036
  2. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
    View in: PubMed
    Score: 0.035
  3. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331.
    View in: PubMed
    Score: 0.034
  4. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.034
  5. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
    View in: PubMed
    Score: 0.034
  6. De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis. 2018 08; 72(2):223-233.
    View in: PubMed
    Score: 0.033
  7. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States. Transplantation. 2017 10; 101(10):2636-2647.
    View in: PubMed
    Score: 0.032
  8. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study. BMC Nephrol. 2017 Jun 17; 18(1):196.
    View in: PubMed
    Score: 0.031
  9. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
    View in: PubMed
    Score: 0.031
  10. Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
    View in: PubMed
    Score: 0.031
  11. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. Am J Kidney Dis. 2017 Jun; 69(6):771-779.
    View in: PubMed
    Score: 0.030
  12. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol. 2016 Mar 29; 67(12):1459-1469.
    View in: PubMed
    Score: 0.028
  13. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
    View in: PubMed
    Score: 0.028
  14. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
    View in: PubMed
    Score: 0.028
  15. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2015 Oct; 30(10):1734-40.
    View in: PubMed
    Score: 0.027
  16. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis. 2015 Oct; 66(4):677-88.
    View in: PubMed
    Score: 0.027
  17. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.027
  18. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
    View in: PubMed
    Score: 0.027
  19. Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant. 2015 Feb; 15(2):499-507.
    View in: PubMed
    Score: 0.026
  20. Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
    View in: PubMed
    Score: 0.026
  21. Heparin use in hemodialysis patients following gastrointestinal bleeding. Am J Nephrol. 2014; 40(4):300-7.
    View in: PubMed
    Score: 0.026
  22. Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
    View in: PubMed
    Score: 0.023
  23. Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. Am J Kidney Dis. 2013 Aug; 62(2):312-21.
    View in: PubMed
    Score: 0.023
  24. Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol. 2013 Apr 26; 14:97.
    View in: PubMed
    Score: 0.023
  25. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013 Jan; 95(1):20-8.
    View in: PubMed
    Score: 0.023
  26. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 06; 126(19):2293-301.
    View in: PubMed
    Score: 0.022
  27. Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
    View in: PubMed
    Score: 0.022
  28. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
    View in: PubMed
    Score: 0.021
  29. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17.
    View in: PubMed
    Score: 0.020
  30. On the relative safety of intravenous iron formulations: new answers, new questions. Am J Hematol. 2010 Sep; 85(9):643-4.
    View in: PubMed
    Score: 0.019
  31. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64.
    View in: PubMed
    Score: 0.019
  32. Altitude and all-cause mortality in incident dialysis patients. JAMA. 2009 Feb 04; 301(5):508-12.
    View in: PubMed
    Score: 0.017
  33. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
    View in: PubMed
    Score: 0.017
  34. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
    View in: PubMed
    Score: 0.016
  35. Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age. Am J Cardiol. 2008 Jun 01; 101(11):1531-6.
    View in: PubMed
    Score: 0.016
  36. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007 Aug; 93(8):945-51.
    View in: PubMed
    Score: 0.015
  37. Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7.
    View in: PubMed
    Score: 0.015
  38. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
    View in: PubMed
    Score: 0.014
  39. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
    View in: PubMed
    Score: 0.014
  40. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
    View in: PubMed
    Score: 0.012
  41. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol. 2004 Apr; 15(4):1052-60.
    View in: PubMed
    Score: 0.012
  42. Hetastarch and bleeding complications after coronary artery surgery. Chest. 2003 Oct; 124(4):1437-42.
    View in: PubMed
    Score: 0.012
  43. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
    View in: PubMed
    Score: 0.012
  44. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis. 2003 Jan; 41(1):84-9.
    View in: PubMed
    Score: 0.011
  45. Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 11 08; 328(18):1837-1848.
    View in: PubMed
    Score: 0.011
  46. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.011
  47. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 06; 31(6):670-679.
    View in: PubMed
    Score: 0.011
  48. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. 2022 01 01; 7(1):75-83.
    View in: PubMed
    Score: 0.011
  49. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021 09 27; 36(10):1893-1899.
    View in: PubMed
    Score: 0.010
  50. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
    View in: PubMed
    Score: 0.010
  51. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
    View in: PubMed
    Score: 0.010
  52. [Hospitalization and Critical Illness in Chronic Kidney Disease]. Cardiorenal Med. 2020; 10(5):302-312.
    View in: PubMed
    Score: 0.009
  53. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.009
  54. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
    View in: PubMed
    Score: 0.009
  55. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.009
  56. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.009
  57. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.008
  58. Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant. 2018 07 01; 33(7):1207-1214.
    View in: PubMed
    Score: 0.008
  59. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622.
    View in: PubMed
    Score: 0.008
  60. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.008
  61. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1778-1786.
    View in: PubMed
    Score: 0.008
  62. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation. 2017 Apr; 101(4):851-857.
    View in: PubMed
    Score: 0.008
  63. Warfarin Initiation, Atrial Fibrillation, and Kidney Function:?Comparative Effectiveness and Safety of?Warfarin?in?Older?Adults?With Newly Diagnosed Atrial?Fibrillation. Am J Kidney Dis. 2017 Jun; 69(6):734-743.
    View in: PubMed
    Score: 0.007
  64. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease. Heart. 2017 06; 103(11):818-826.
    View in: PubMed
    Score: 0.007
  65. Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis. 2017 Feb; 69(2):237-246.
    View in: PubMed
    Score: 0.007
  66. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.007
  67. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. 2016 05; 16(5):1492-502.
    View in: PubMed
    Score: 0.007
  68. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
    View in: PubMed
    Score: 0.007
  69. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis. Arthritis Care Res (Hoboken). 2015 Oct; 67(10):1453-62.
    View in: PubMed
    Score: 0.007
  70. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients. Am J Kidney Dis. 2016 Jan; 67(1):119-27.
    View in: PubMed
    Score: 0.007
  71. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ. 2015 Feb 03; 350:h246.
    View in: PubMed
    Score: 0.007
  72. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
    View in: PubMed
    Score: 0.006
  73. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014 Aug 19; 64(7):660-8.
    View in: PubMed
    Score: 0.006
  74. Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):157-62.
    View in: PubMed
    Score: 0.006
  75. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8(11):e78930.
    View in: PubMed
    Score: 0.006
  76. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 Jun; 24(7):1151-8.
    View in: PubMed
    Score: 0.006
  77. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013 Jun; 126(6):541.e1-541.e14.
    View in: PubMed
    Score: 0.006
  78. Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012 Dec; 125(12):1195-1204.e3.
    View in: PubMed
    Score: 0.006
  79. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012 Aug; 64(8):2669-76.
    View in: PubMed
    Score: 0.006
  80. Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child. 2010 Aug; 95(8):634-8.
    View in: PubMed
    Score: 0.005
  81. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1189-96.
    View in: PubMed
    Score: 0.004
  82. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol. 2007 Aug; 22(8):1189-93.
    View in: PubMed
    Score: 0.004
  83. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol. 2006 Jun; 17(6):1688-94.
    View in: PubMed
    Score: 0.004
  84. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
    View in: PubMed
    Score: 0.004
  85. Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure. Circulation. 2005 Dec 13; 112(24):3745-53.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.